Study confirms efficacy of Novartis's dispersible malaria tablet for children
This article was originally published in Scrip
Executive Summary
Novartis's dispersible, flavoured antimalarial tablet formulation of its artemether-lumefantrine combination, Coartem, was as effective as the current conventional tablet treatment when crushed, a Tanzanian study published in The Lancet has found.